DABLE HABIB J (CEO and President) sold 50.4% of their position (100K shares) of ACCELERON PHARMA INC on the open market

Open‑market sale worth $12.68M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales

DABLE HABIB J

Filed: 7/2/2021ACC: 0001179110-21-007353

InsiderDABLE HABIB JCIK 1690773

→

IssuerACCELERON PHARMA INCCIK 1280600

DirectorOfficer· CEO and President

Since Dec 2018

-100K

Net shares

Net seller

$12.68M

Total sold

Open market trades

0B · 8S

Total transactions

100K acquired · 200K disposed

Non-Derivative Transactions10

Common Stock

Direct

M · Option Exercise

+57.81K

Price / share

$35.04

Trade value

$2.03M

% of position

58.7%

7/1/2021

98.45K→156.26K

Common Stock

Direct

S · Sale

−11.85K

Price / share

$125.15

Trade value

$1.48M

% of position

7.6%

7/1/2021

156.26K→144.42K

Common Stock

Direct

S · Sale

−9.19K

Price / share

$125.81

Trade value

$1.16M

% of position

6.4%

7/1/2021

144.42K→135.22K

Common Stock

Direct

S · Sale

−23.16K

Price / share

$126.85

Trade value

$2.94M

% of position

17.1%

7/1/2021

135.22K→112.06K

Common Stock

Direct

S · Sale

−4.56K

Price / share

$127.89

Trade value

$583.18K

% of position

4.1%

7/1/2021

112.06K→107.50K

Common Stock

Direct

S · Sale

−9.05K

Price / share

$128.82

Trade value

$1.17M

% of position

8.4%

7/1/2021

107.50K→98.45K

Common Stock

Direct

M · Option Exercise

+42.19K

Price / share

$35.04

Trade value

$1.48M

% of position

42.9%

7/2/2021

98.45K→140.64K

Common Stock

Direct

S · Sale

−29.14K

Price / share

$126.69

Trade value

$3.69M

% of position

20.7%

7/2/2021

140.64K→111.50K

Common Stock

Direct

S · Sale

−11.46K

Price / share

$127.51

Trade value

$1.46M

% of position

10.3%

7/2/2021

111.50K→100.04K

Common Stock

Direct

S · Sale

−1.59K

Price / share

$128.21

Trade value

$203.60K

% of position

1.6%

7/2/2021

100.04K→98.45K

Total

Net shares

+0.00

Net value

-$9.18M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	7/1/2021	M · Option Exercise	+57.81K	$35.04	$2.03M	58.7%	98.45K	156.26K
Common Stock Direct	7/1/2021	S · Sale	−11.85K	$125.15	$1.48M	7.6%	156.26K	144.42K
Common Stock Direct	7/1/2021	S · Sale	−9.19K	$125.81	$1.16M	6.4%	144.42K	135.22K
Common Stock Direct	7/1/2021	S · Sale	−23.16K	$126.85	$2.94M	17.1%	135.22K	112.06K
Common Stock Direct	7/1/2021	S · Sale	−4.56K	$127.89	$583.18K	4.1%	112.06K	107.50K
Common Stock Direct	7/1/2021	S · Sale	−9.05K	$128.82	$1.17M	8.4%	107.50K	98.45K
Common Stock Direct	7/2/2021	M · Option Exercise	+42.19K	$35.04	$1.48M	42.9%	98.45K	140.64K
Common Stock Direct	7/2/2021	S · Sale	−29.14K	$126.69	$3.69M	20.7%	140.64K	111.50K
Common Stock Direct	7/2/2021	S · Sale	−11.46K	$127.51	$1.46M	10.3%	111.50K	100.04K
Common Stock Direct	7/2/2021	S · Sale	−1.59K	$128.21	$203.60K	1.6%	100.04K	98.45K
Total			+0.00		-$9.18M

Derivative Transactions2

Option to Purchase Common Stock

Direct

M · Option Exercise

Converts to

Common Stock

57.81K shares

−57.81K

Strike price

35.04

Held after

292.19K

Exercisable

—

7/1/2021

Option to Purchase Common Stock

Direct

M · Option Exercise

Converts to

Common Stock

42.19K shares

−42.19K

Strike price

35.04

Held after

250K

Exercisable

—

7/2/2021

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Option to Purchase Common Stock Direct	Common Stock57.81K shares	7/1/2021	M · Option Exercise	−57.81K	35.04	—	292.19K
Option to Purchase Common Stock Direct	Common Stock42.19K shares	7/2/2021	M · Option Exercise	−42.19K	35.04	—	250K